<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Saarland_Labbook"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Saarland/Labbook">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Saarland/Labbook&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Saarland/Labbook&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Saarland/Labbook&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Saarland/Labbook" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Saarland/Labbook</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV id="wikicontent-container"><DIV><DIV id="menu"><UL><LI><A id="team1" href="https://2014.igem.org/Team:Saarland/Team">Team</A></LI><LI><A id="members" href="https://2014.igem.org/Team:Saarland/Team">Members</A></LI><LI><A id="official" href="https://igem.org/Team.cgi">Official Team Profile</A></LI><LI><A id="press" href="https://2014.igem.org/Team:Saarland/Press">Publicity</A></LI><LI><A id="attribution" href="https://2014.igem.org/Team:Saarland/Attribution">Attributions</A></LI><LI><A id="sponsors" href="https://2014.igem.org/Team:Saarland/Sponsors">Sponsors</A></LI><LI><A id="judging" href="https://2014.igem.org/Team:Saarland/Judging">Judging</A></LI></UL><LI><A id="project3" href="https://2014.igem.org/Team:Saarland/Project">Project</A></LI><LI><A id="project2" href="https://2014.igem.org/Team:Saarland/Project">Overview</A></LI><LI><A id="1." href="https://2014.igem.org/Team:Saarland/anticancergens#thenackedmolerat">Naked mole rat</A></LI><LI><A id="1." href="https://2014.igem.org/Team:Saarland/anticancergens#hyaloronicacid">Hyaluronic acid</A></LI><LI><A id="1." href="https://2014.igem.org/Team:Saarland/anticancergens#HMM-HA">HMM-HA</A></LI><LI><A id="2." href="https://2014.igem.org/Team:Saarland/2_step">B.megaterium </A></LI><LI><A id="2." href="https://2014.igem.org/Team:Saarland/2_step#pathway">Pathway engineering </A></LI><LI><A id="3." href="https://2014.igem.org/Team:Saarland/3_step">Develop Strategy </A></LI><LI><A id="results" href="https://2014.igem.org/Team:Saarland/4_step">Results</A></LI><LI><A id="erg" href="https://2014.igem.org/Team:Saarland/4_step">Results </A></LI><LI><A id="5." href="https://2014.igem.org/Team:Saarland/5_step">Discussion </A></LI><LI><A id="5." href="https://2014.igem.org/Team:Saarland/5_step#outlook">Outlook </A></LI><LI><A id="parts" href="https://2014.igem.org/Team:Saarland/Parts">Parts</A></LI><LI><A id="modeling" href="https://2014.igem.org/Team:Saarland/Modeling">Modelling</A></LI><LI><A id="rpg" href="https://2014.igem.org/Team:Saarland/rpg">Human Resources</A></LI><LI><A id="notebook" href="https://2014.igem.org/Team:Saarland/Labbook">Notebook</A></LI><LI><A id="labbook" href="https://2014.igem.org/Team:Saarland/Labbook">Lab journal</A></LI><LI><A id="Methods" href="https://2014.igem.org/Team:Saarland/Methods">Methods</A></LI><LI><A id="Materials" href="https://2014.igem.org/Team:Saarland/Materials">Materials</A></LI><LI><A id="safety" href="https://2014.igem.org/Team:Saarland/Safety">Safety </A></LI></DIV></DIV></DIV><DIV id="wikicontent-container"><DIV id="wikicontent"><H1><SPAN class="mw-headline" id="Lab_journal"> Lab journal </SPAN></H1><P><I> Skip to a month by clicking the corresponding marking above </I></P><H3><SPAN class="mw-headline" id="February"> February</SPAN></H3>Develop strategy for the first ever biotechnological production of the naked mole rat´s high molecular mass hyaluronic acid and the characterisation of its inhibitory effects on carcinogenesis.
<UL><LI>Recruiting committed team members.
</LI><LI> The naked mole rat RUFUS took up residence in our lab
</LI></UL><H3><SPAN class="mw-headline" id="March"> March </SPAN></H3><UL><LI>Looking for sponsors.
</LI><LI>Team registration.
</LI></UL><H3><SPAN class="mw-headline" id="April">April</SPAN></H3><UL><LI>Looking for sponsors
</LI><LI>Design of a team logo
</LI></UL><H3><SPAN class="mw-headline" id="May">May</SPAN></H3><UL><LI>Looking for sponsors
</LI><LI>Conception and design of the team wiki
</LI></UL><P>Waiting for completion of <I>has</I>2 gene synthesis.
</P><H4><SPAN class="mw-headline" id="Highlight_at_Week_4">Highlight at Week 4</SPAN></H4><UL><LI>Meet up of German iGEM teams in Munich. Inspiring Weekend. We enjoyed the short trip.
</LI></UL><H3><SPAN class="mw-headline" id="June">June</SPAN></H3><H4><SPAN class="mw-headline" id="1._Week">1. Week</SPAN></H4>Finally, the synthesised <I>has</I>2 gene has arrived! 
<P>Transformation of electro competent <I>E. coli</I> cells with Eurofins standard delivery plasmid pexK4 containing the synthesised <I>has</I>2 insert DNA.
</P>Plasmid preparation and control digestion to confirm the presence of <I>has</I>2 insert DNA.
<H4><SPAN class="mw-headline" id="2._Week">2. Week</SPAN></H4>First attempt to insert <I>has</I>2 DNA into the multiple cloning site (MCS) of pSMF2.1 plasmid construct. This shuttle plasmid allows on the one hand the amplification of plasmid DNA in high copy numbers in <I>E. coli</I> cells. On the other hand pSMF2.1 is optimised for expression of recombinant proteins in our favourite chassis <I>B. megaterium. Has</I>2 insert DNA was absent in transformants.
<H4><SPAN class="mw-headline" id="3._Week">3. Week</SPAN></H4>Repetition of cloning experiments (week 2) with new T4 ligase provided many <I>E. coli </I>transformants with pSMF2.1 plasmid construct containing <I>has</I>2 insert DNA.
<H4><SPAN class="mw-headline" id="4._Week">4. Week</SPAN></H4><P>Extraction of genomic DNA from <I>B. megaterium</I> was performed. 
</P>Optimal PCR conditions for the amplification of genomic DNA from <I>B. megaterium </I>were tested. First gene (<I>UDP-glc</I>DH) involved in synthesis of precursor molecules and probably contributing to a high yield production of high molecular mass hyaluronic acid was successfully amplified. 
<P>First attempt for downstream insertion of <I>UDP-glc</I>DH DNA into the MCS of pSMF2.1 plasmid construct that already contained the <I>has</I>2 insert DNA was successful. 
</P><H3><SPAN class="mw-headline" id="July">July</SPAN></H3><H4><SPAN class="mw-headline" id="1._Week_2">1. Week</SPAN></H4><UL><LI>Open day at Saarland University. The iGEM team was proud to present its project to the general public. 
</LI></UL>Plasmid preparation and control digestion to confirm the simultaneous presence of <I>has</I>2 and <I>UDP-glc</I>DH insert DNA in the pSMF2.1 plasmid construct.
Preparation of fresh protoplasts for transformation of <I>B. megaterium</I> strain MS941 was successful. Competence is outstanding.
<H4><SPAN class="mw-headline" id="2._Week_2">2. Week</SPAN></H4>Transformations of <I>B. megaterium</I> protoplasts with different pSMF2.1 plasmid constructs were successful. Screening process for the identification of <I>B. megaterium</I> transformants with correct plasmid constructs was time consuming.
<I>B. megaterium</I> chassis for the first ever biotechnological production of high molecular mass hyaluronic acid is ready!
<H4><SPAN class="mw-headline" id="3._Week_2">3. Week</SPAN></H4>Cultivation of <I>B. megaterium</I> and induction of recombinant protein production were performed. Samples were prepared after an appropriate cultivation time to check and characterise recombinant protein expression levels of Has2 and UDP-GlcDH. 
These samples were also used for viscosity measurement since the outstanding water binding capacity of high molecular mass hyaluronic acid should increase the viscosity of the cultivation medium. 
<H4><SPAN class="mw-headline" id="4._Week_2">4. Week</SPAN></H4> Illegal restriction sites within <I>has</I>2 and <I>UDP-glc</I>DH were changed via QC-PCR. Resulting biobrick DNAs were inserted into the standard biobrick plasmid construct pSB1C3. 
Measurement of viscosity was performed. There was no difference in viscosity of the culture medium and consequently no high molecular mass hyaluronic acid production detectable in the first attempt.
<H3><SPAN class="mw-headline" id="August">August</SPAN></H3><H4><SPAN class="mw-headline" id="1._Week_3">1. Week</SPAN></H4><P>SDS-PAGE 
</P><P>Power failure at whole Saarland University during weekend. Reorder of heat sensitive enzymes including polymerases, restriction enzymes and ligase. 
</P><P>Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project
</P><H4><SPAN class="mw-headline" id="2._Week_3">2. Week</SPAN></H4><P>Functional enzymes arrived. 
</P>Repetition of all <I>B. megaterium</I> transformations during timeout since corresponding glycerol stocks were damaged. 
<P><SPAN style="margin-top:-20px"> Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project</SPAN></P><H4><SPAN class="mw-headline" id="3._Week_3">3. Week</SPAN></H4>Generation of <I>has2-gfp</I> fusion gene via SOE-PCR for quick evaluation of Has2 expression level and localisation in <I>B. megaterium</I> was performed. Insertion of <I>has2-gfp</I> fusion gene into MCS of pSMF2.1 plasmid construct was successful. A lot of positive <I>E. coli</I> transformants!
<P>Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project
</P><H4><SPAN class="mw-headline" id="4._Week_3">4. Week</SPAN></H4>Plasmid preparation and transformation of fresh prepared <I>B. megaterium</I> protoplasts with pSMF2.1 plasmid construct containing the <I>has2-gfp</I> fusion gene was successful.Expression of Has-GFP fusion protein and samples for localisation studies via fluorescence microscopy were prepared. 
<P>Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project
</P><H3><SPAN class="mw-headline" id="September">September</SPAN></H3><H4><SPAN class="mw-headline" id="1._Week_4">1. Week</SPAN></H4><UL><LI>Meet and greet with our sponsors. Thank you very much for your great support!
</LI></UL>First attempt to confirm Has-GFP expression via epi fluorescence microscopy was successful. <I>B. megaterium</I> cells glew beautifully green. 
Additional genes involved in synthesis of precursor molecules were successfully amplified from genomic DNA of <I>B. megaterium</I> and inserted into the standard biobrick plasmid construct pSB1C3. 
<P>Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project.
</P><UL><LI> Evaluation of results and creation of figures for our team wiki.
</LI></UL><H4><SPAN class="mw-headline" id="2._Week_4">2. Week</SPAN></H4>Expression of Has-GFP fusion protein was repeated and samples for localisation studies via laser scanning microscopy were prepared. No fluorescence signal was detectable after cultivation under the same conditions.
<P>Illegal restriction sites within the genes for pathway engineering were changed via QC-PCR.
</P><P>Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project.
</P><UL><LI>Evaluation of results and creation of figures for our team wiki.
</LI></UL><H4><SPAN class="mw-headline" id="3._Week_4">3. Week</SPAN></H4>Expression of Has-GFP fusion protein was tested under different cultivation conditions. No significant fluorescence signal. Possible misfolding of Has-GFP protein
<P>Sequencing of biobricks was prepared.
</P><P>Western blot of Has-GFP to determine the presence of misfolded protein.
</P><P>Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project.
</P><UL><LI>Evaluation of results and creation of figures for our team wiki.
</LI></UL><H4><SPAN class="mw-headline" id="4._Week_4">4. Week</SPAN></H4><P>Waiting for sequencing results.
</P><P>Human Practices: Design and development of the roleplaying game for the ethical and social implications of our project.
</P><UL><LI>Evaluation of results and creation of figures for our team wiki.
</LI></UL><H3><SPAN class="mw-headline" id="October">October</SPAN></H3><H4><SPAN class="mw-headline" id="1._Week_5">1. Week</SPAN></H4><P>BioBrick sequencing was finished. BioBricks are ready to ship to the iGEM Headquarter.
</P><P>Human Practices: Beta test of the roleplaying game for the ethical and social implications of our project.
</P><UL><LI>Evaluation of results and creation of figures for our team wiki.
</LI></UL><H4><SPAN class="mw-headline" id="2._Week_5">2. Week</SPAN></H4><UL><LI>Last modifications on team wiki!
</LI></UL><P>Human Practices: Last modifications of the roleplaying game for the ethical and social implications of our project.
</P></DIV></DIV><DIV id="social-footer"><DIV><H4><A href="https://2014.igem.org/Team:Saarland/Impressum">Impressum/Copyright</A></H4></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Saarland/Labbook">http://2014.igem.org/Team:Saarland/Labbook</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Saarland/Labbook" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Saarland/Labbook" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Saarland/Labbook&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Saarland/Labbook&amp;oldid=324526" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>